ArticleFrontiers in cell and developmental biology2025
A switch from α5β1 to αvβ3 integrin activity contributes to the development of a profibrotic mesenchymal phenotype in trabecular meshwork cells.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrin α4 and α9 in trabecular meshwork and Schlemm's canal function: emerging regulators of intraocular pressure homeostasis.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Purpose: Fibrogenic changes in the trabecular meshwork (TM) are considered to be a major cause for the restriction in aqueous humor outflow from the anterior chamber associated with primary open angle glaucoma. In this study, we investigated whether integrin switching from α5β1 to αvβ3 integrin expression could initiate fibrotic-like changes in the TM that could restrict outflow. Methods: Human TM cells were isolated from young (<40 years) and old (>50 years) donor eyes. RT-PCR, western blots and immunofluorescence microscopy were used to evaluate levels of integrin and αSMA expression. Lentiviral shRNA vectors were used to knockdown α5 and β3 integrin levels. Paraffin embedded anterior segments of young and old donor eyes were used to evaluate αSMA levels Results: Studies revealed an age-related decrease in α5 integrin mRNA expression in TM cells. This loss was accompanied by an increase in αSMA mRNA and protein levels and an increase in activated αvβ3 integrin levels. Knockdown of β3 integrin mRNA and protein levels decreased the expression of αSMA mRNA and protein levels. Elevated mRNA levels of the EndMT biomarkers, Conclusion: These studies suggest that crosstalk between α5β1 and αvβ3 integrin signaling controls expression of αSMA mRNA and protein levels and that β3 integrins may play a role in the development of the fibrogenic phenotype in TM cells and associated with POAG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.